Cadila Pharmaceuticals Limited

Cadila Pharmaceuticals Limited is one of India's largest privately held pharmaceutical companies, headquartered in Ahmedabad, Gujarat. Founded in 1952 by the late Shri Indravadan A. Modi, the company has grown into a multinational pharmaceutical enterprise committed to developing and manufacturing high-quality, affordable medicines. The company's diverse portfolio includes pharmaceutical formulations, active pharmaceutical ingredients (APIs), generic medicines, biotechnology products, herbal healthcare solutions and contract manufacturing services. Its products address a wide range of therapeutic areas, including cardiology, gastroenterology, oncology, diabetology, neurology, respiratory care, gynaecology and anti-infective treatments.

Research and development is central to Cadila's operations, supporting the discovery of innovative therapies, formulation development and improvements in pharmaceutical manufacturing. The company operates manufacturing facilities and research centres equipped to serve domestic and international markets.Cadila Pharmaceuticals has established a significant global presence, supplying medicines to more than 100 countries through its international operations and distribution networks. Its manufacturing capabilities, scientific expertise and focus on quality enable it to address diverse healthcare needs worldwide. 

The company emphasises innovation, affordability, quality, ethical business practices and patient well-being. Through its healthcare initiatives and corporate social responsibility programmes, it also contributes to community development and improved access to medical services. With more than seven decades of pharmaceutical experience, Cadila Pharmaceuticals continues to advance healthcare through scientific research, reliable manufacturing and accessible treatment solutions, reinforcing its commitment to improving lives in India and across the globe.